Reoperation after Cardiac Valve Surgery: Elective, Urgent and Emergent

  • James R. Pluth


During the 1970s there was a trend toward the use of tissue or heterograft valves in order to avoid the high rate of thromboembolism and anticoagulant related complications associated with mechanical prostheses. Use of bioprostheses appears to have reduced thromboembolic complications, but unfortunately, bioprosthesis must still be considered a temporary valve substitute. Due to its limited durability, one must consider the risks of future reoperation for valve replacement when weighing the potential benefits of a bioprosthesis. This chapter assesses the risks of valve reoperation and its effect on subsequent longevity.


Valve Replacement Infectious Endocarditis Mechanical Prosthesis Cardiac Valve Replacement Paravalvular Regurgitation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Martinus Nijhoff Publishing, Boston 1985

Authors and Affiliations

  • James R. Pluth

There are no affiliations available

Personalised recommendations